Introduction:Basic information about CAS 828934-41-4|Etomoxir (Na salt), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Etomoxir (Na salt) |
|---|
| CAS Number | 828934-41-4 | Molecular Weight | 320.744 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C15H18ClNaO4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | sodium,(2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate |
|---|
| Synonym | More Synonyms |
|---|
Etomoxir (Na salt) BiologicalActivity
| Description | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
|---|
| Target | CPT-1[1] |
|---|
| In Vitro | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig[1]. |
|---|
| References | [1]. Agius L, et al. Differences between human, rat and guinea pig hepatocyte cultures. A comparative study of their rates of beta-oxidation and esterification of palmitate and their sensitivity to R-etomoxir. Biochem Pharmacol. 1991 Oct 9;42(9):1711-5. |
|---|
Chemical & Physical Properties
| Molecular Formula | C15H18ClNaO4 |
|---|
| Molecular Weight | 320.744 |
|---|
| Exact Mass | 320.079132 |
|---|
| PSA | 61.89000 |
|---|
| LogP | 2.18820 |
|---|
| InChIKey | RPACBEVZENYWOL-XFULWGLBSA-M |
|---|
| SMILES | O=C([O-])C1(CCCCCCOc2ccc(Cl)cc2)CO1.[Na+] |
|---|
| Storage condition | -20℃ |
|---|
Safety Information
| Hazard Codes | Xn: Harmful; |
|---|
| Risk Phrases | 22 |
|---|
| RIDADR | UN 2811 6.1/PG 3 |
|---|
Synonyms
| Sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylate |
| 2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)- (1:1) |
| cc-140 |
| (+)-Etomoxir (sodium salt) |
| ANTI-EAPII(TTRAP) |
| (2R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid sodium salt |
| MFCD07787411 |
| (+)-Etomoxir sodium salt |
| (R)-(+)-Etomoxir (sodium salt) |